Oncology

Our people

Home / Our company / Our people / Oncology

Our Oncology is focusing on some of the most hostile and hard-to-treat cancers. By understanding the complexities of cancer, we hope to achieve life-changing benefits for patients.

Anas Younes

Senior Vice President, Global Head of Haematology (Early and Late Stage) Oncology R&D
Andrew Foxley

Vice President, Franchise Head, Late Oncology R&D
 
Bob T. Li

Global Head of Medical Affairs, Oncology, AstraZeneca
Cristian Massacesi

Chief Medical Officer and Oncology Chief Development Officer
Gemma Satterthwaite

Global Product Leader, Oncology Business Unit
Helen Angell

Director, Translational Medicine, Oncology Research & Early Development
Ingrid A. Mayer

Global Clinical Head for Breast Cancer and Breast Cancer Strategy
Leora Horn

Global Clinical Head for Lung Cancer and Lung Cancer Strategy
Mark Cobbold

Vice President, Discovery, Oncology R&D

Explore our people in other business units

R&D
BioPharmaceutical
Rare Disease
Enabling Functions
Operations
International

Veeva ID: Z4-70553
Date of preparation: November 2024